NPR’s health blog “Shots” describes how scientists are targeting biological structures called apicoplasts in malaria parasites in developing new medications to fight the infection. Without apicoplasts, which are not common in most species, malaria parasites die, so a drug developed to target them would theoretically kill the parasites, the blog notes.

Apicoplasts have their own DNA, which is separate from the DNA of the parasite and is closely related to algal DNA. “‘It’s actually thought that the malaria parasite incorporated an algal cell early on, and that the thing we call the apicoplast is the remnant of the algal cell,’ says Sean Prigge at the Johns Hopkins Malaria Institute,” the blog notes. “So a remnant of algae may help bring down one of the world’s most deadly parasites,” according to “Shots” (Palca, 8/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.